Status:
COMPLETED
Reproducibility Study of Over Active Bladder Symptom Score [OABSS]
Lead Sponsor:
Astellas Pharma Inc
Collaborating Sponsors:
Astellas Pharma China, Inc.
Conditions:
Overactive Bladder
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the reproducibility of over active bladder symptom score (OABSS) in Asian countries.
Eligibility Criteria
Inclusion
- Symptoms OAB for 3 months or longer
- At least 1 urgency episode in last 3 days
- Symptoms of OAB as verified by the screening 3-day bladder diary, defined by:
- Number of micturition ≥8 times/day
- Number of urgency episode in 3 days ≥1
Exclusion
- Indwelling catheters or practicing intermittent self-catheterization
- Symptomatic urinary tract infection, chronic inflammation
- Diabetic neuropathy
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00901251
Start Date
January 1 2009
End Date
May 1 2009
Last Update
March 15 2011
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing, China
2
Chongqing, China
3
Shanghai, China
4
Shenyang, China